An expert at ESMO 2026 explains how liquid biopsy and ESR1 testing can help guide treatment for people with HR-positive metastatic breast cancer.
|Videos|December 21, 2015
Sherry Fox on What It Means to Be a GBM Hero
Author(s)Sherry Fox
Sherry Fox accepts her award as one of our 2015 GBM Heroes.
Advertisement
Sherry Fox, director of Quality of Life Programs and Services at the Cullather Brain Tumor Quality of Life Center in Richmond, Va., accepts her award as one of our
Advertisement
Related to this article
Psychiatrist Dr. Yesne Alici of Memorial Sloan Kettering Cancer Center answers questions about family relationships during cancer, from asking for help to talking with children and friends.
After breast cancer at 30, Aisha shares her journey through motherhood, a double mastectomy, body image struggles and the challenges of survivorship.
Emma Halligan found connection at a free New Jersey retreat for women with cancer, which held its annual walk and 5K on Oct. 17.
Diagnosed with stage 4 breast cancer weeks after giving birth, Eileen Carter explains why getting a second opinion changed the course of her care.
Noah Elliott, now a Paralympic snowboarder, counted small wins during inpatient chemotherapy and found inspiration in the youngest children on his hospital floor.
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Talzenna Plus Xtandi in Hormone-Sensitive Prostate Cancer
2
Working During Cancer Treatment: Your FMLA and ADA Rights
3
What Liquid Biopsy and ESR1 Mutations Mean in Breast Cancer
4
FDA Grants Traditional Approval to Keytruda for TMB-H Solid Tumors
5